Samsung Biologics Co Ltd
KRX:207940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
P/S Valuation Scenarios
If P/S returns to its 3-Year Average (18.9), the stock would be worth ₩1 044 125.59 (4% upside :side from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 18.1 | ₩1 000 000 |
0%
|
| 3-Year Average | 18.9 | ₩1 044 125.59 |
+4%
|
| 5-Year Average | 22.9 | ₩1 270 552.67 |
+27%
|
| Industry Average | 8.4 | ₩465 585.72 |
-53%
|
| Country Average | 1 | ₩58 059.73 |
-94%
|
Forward P/S
Today's price vs future Revenue
| Current Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
₩82.3T
|
/ |
Dec 2025
₩4.6T
|
= |
|
|
₩82.3T
|
/ |
Dec 2026
₩5.8T
|
= |
|
|
₩82.3T
|
/ |
Dec 2027
₩6.6T
|
= |
|
|
₩82.3T
|
/ |
Dec 2028
₩6.9T
|
= |
|
Forward P/S shows whether today's P/S still looks high or low once future Revenue are taken into account.